EXOMED THERAPEUTICS
(EXOMED THERAPEUTICS PRIVATE LIMITED)
Founded in 2022
About EXOMED THERAPEUTICS
Exomed Therapeutics Private Limited is a product and research development startup harnessing the potential of exosome biology to develop novel and affordable solutions for diabetes, related complications, and other diseases. Their flagship product is a therapeutic option for diabetes mellitus, a metabolic disorder.
Incubators & Accelerators of EXOMED THERAPEUTICS
Frequently Asked Questions (FAQ)
When was EXOMED THERAPEUTICS founded?
EXOMED THERAPEUTICS was founded in the year 2022.
What is the legal name of EXOMED THERAPEUTICS?
The legal name of EXOMED THERAPEUTICS is Exomed Therapeutics Private Limited.
Who are the founders of EXOMED THERAPEUTICS?
EXOMED THERAPEUTICS is founded by Sreekanth Jaganmani and Sreekanth Patnam.
Which Incubators & Accelerators supported EXOMED THERAPEUTICS?
What are the focus areas of EXOMED THERAPEUTICS?
Who are EXOMED THERAPEUTICS's competitors?
Possible competitors of EXOMED THERAPEUTICS may include Alantis Sciences India, Aarna Therapeutics, Cellogen Therapeutics Private Limited and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
